Clinical application of biochemical markers of bone turnover.
With the ageing population in most countries, disorders of bone and mineral metabolism are becoming increasingly relevant to every day clinical practice. Consequently, the interest in, and the need for effective measures to be used in the screening, diagnosis and follow-up of such pathologies have markedly grown. Together with clinical and imaging techniques, biochemical tests play an important role in the assessment and differential diagnosis of metabolic bone disease. In recent years, the isolation and characterisation of cellular and extracellular components of the skeletal matrix have resulted in the development of molecular markers that are considered to reflect either bone formation or bone resorption. These biochemical indices are non-invasive, comparatively inexpensive and, when applied and interpreted correctly, helpful tools in the diagnostic and therapeutic assessment of metabolic bone disease. This review provides an overview of the current evidence regarding the clinical use of biochemical markers of bone remodelling in bone disease, with an emphasis on osteoporosis.
Seibel
Markus J
MJ
Department of Endocrinology, University of Sydney-Concord Campus, Australia. mjs@anzac.edu.au
D015415:Biomarkers / Q000032:analysis* / Q000097:blood / Q000652:urine; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000378:metabolism* / Q000652:urine; D001862:Bone Resorption / Q000097:blood / Q000378:metabolism* / Q000652:urine; D001842:Bone and Bones / Q000737:chemistry / Q000378:metabolism*; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000378:metabolism*; D006620:Hip Fractures / Q000209:etiology / Q000378:metabolism; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000097:blood / Q000175:diagnosis* / Q000652:urine; D015663:Osteoporosis, Postmenopausal / Q000378:metabolism; D012307:Risk Factors
D015415:Biomarkers